E
Y. Nanba et al.
Letter
Synlett
(6) (a) Miyaoka, H.; Hara, Y.; Shinohara, I.; Kurokawa, T.; Yamada, Y.
Tetrahedron Lett. 2005, 46, 7945. (b) Alami, M.; Linstrumelle, G.
Tetrahedron Lett. 1991, 32, 6109.
(7) (a) Avignon-Tropis, M.; Treilhou, M.; Pougny, J. R.; Fréchard-
Ortuno, I.; Linstrumelle, G. Tetrahedron 1991, 47, 7279.
(b) Nicolaou, K. C.; Webber, S. E. J. Am. Chem. Soc. 1984, 106,
5734.
1.20–1.66 (m, 9 H), 4.08–4.22 (m, 1 H), 5.72 (dd, J = 15.9 Hz, 1.5
Hz, 1 H), 6.20 (dd, J = 15.9, 6.3 Hz, 1 H) ppm. 13C–APT NMR (75
MHz, CDCl3): δ = –0.05 (+), 14.1 (+), 22.6 (–), 25.0 (–), 31.8 (–),
36.9 (–), 72.3 (+), 95.1 (–), 103.2 (–), 109.8 (+), 147.0 (+) ppm.
HRMS (FAB+): m/z [M + Na]+ calcd for C13H24OSiNa: 247.1494;
found: 247.1490.
(12) Nanba, Y.; Shinohara, R.; Morita, M.; Kobayashi, Y. Org. Biomol.
Chem. 2017, 15, 8614.
(8) (a) Suh, Y.-G.; Min, K.-H.; Lee, Y.-S.; Seo, S.-Y.; Kim, S.-H.; Park,
H.-J. Tetrahedron Lett. 2002, 43, 3825. (b) Yadav, J. S.; Barma, D.
K.; Dutta, D. Tetrahedron Lett. 1997, 38, 4479. (c) Alami, M.;
Crousse, B.; Linstrumelle, G.; Mambu, L.; Larchevêqu, M. Tetra-
hedron: Asymmetry 1997, 8, 2949. (d) Hearn, M. T. W.; Jones, E.
R. H.; Pellatt, M. G.; Thaller, V.; Turner, J. L. J. Chem. Soc., Perkin
Trans. I 1973, 2785.
(9) Previous syntheses of 18-HEPE: (a) Kato, T.; Nakai, T.; Ishikawa,
R.; Iio, Y. Heterocycles 2002, 56, 119. (b) Krishnamurthy, V. R.;
Dougherty, A.; Haller, C. A.; Chaikof, E. L. J. Org. Chem. 2011, 76,
5433. (c) Isobe, Y.; Arita, M.; Matsueda, S.; Iwamoto, R.;
Fujihara, T.; Nakanishi, H.; Taguchi, R.; Masuda, K.; Sasaki, K.;
Urabe, D.; Inoue, M.; Arai, H. J. Biol. Chem. 2012, 287, 10525.
(10) (a) Serhan, C. N.; Clish, C. B.; Brannon, J.; Colgan, S. P.; Chiang,
N.; Gronert, K. J. Exp. Med. 2000, 192, 1197. (b) Arita, M.;
Bianchini, F.; Aliberti, J.; Sher, A.; Chiang, N.; Hong, S.; Yang, R.;
Petasis, N. A.; Serhan, C. N. J. Exp. Med. 2005, 201, 713. (c) Oh, S.
F.; Pillai, P. S.; Recchiuti, A.; Yang, R.; Serhan, C. N. J. Clin. Invest.
2011, 121, 569.
(13) (a) Spinella, A.; Caruso, T.; Martino, M.; Sessa, C. Synlett 2001,
1971. (b) Caruso, T.; Spinella, A. Tetrahedron 2003, 59, 7787.
(14) (a) Ng, C. Y.; Kwok, T. X. W.; Tan, F. C. K.; Low, C.-M.; Lam, Y.
Chem. Commun. 2017, 53, 1813. (b) Li, C.; Xu, W.; Vadivel, S. K.;
Fan, P.; Makriyannis, A. J. Med. Chem. 2005, 48, 6423.
(15) Castro–Stephens coupling of rac-7 (1.2 equiv) with Z-allylic
bromide i (1 equiv) using CuI (2 equiv), NaI (2 equiv), and K2CO3
(1.5 equiv) at rt in DMF gave a mixture of rac-12 and the regio-
isomer ii in a 3:1 ratio (1H NMR), which were hardly separated
by chromatography on silica gel (Scheme 6). The mixture was
converted into 18-HEPE and the regioisomer by a sequence of
reactions: 1) TBAF; 2) Zn (Cu/Ag); 3) LiOH; an attempted sepa-
ration at each step was hardly successful.
CO2Me
CuI (2 equiv), NaI (2 equiv),
K2CO3 (1.5 equiv)
+
rac-7
DMF, rt, 8 h
63%
Br
i (1 equiv)
(1.2 equiv)
(11) To an ice-cold solution of 2a (0.40 mL, 2.89 mmol) and n-BuLi
(1.55 M in hexane, 1.60 mL, 2.48 mmol) in THF (0.1 mL) were
added HMPA (0.95 mL, 5.44 mmol) and a solution of 1a (anti)
(65 mg, 0.30 mmol) in THF (0.2 mL). After being stirred at rt for
3 h, the solution was diluted with saturated NH4Cl. The mixture
was extracted with EtOAc and the crude product was purified
by chromatography on silica gel (hexane/EtOAc) to afford enyne
rac-3a (41 mg, 60%). Liquid, Rf = 0.43 (hexane/EtOAc 9:1). 1H
NMR (300 MHz, CDCl3): δ = 0.19 (s, 9 H), 0.88 (t, J = 6.9 Hz, 3 H),
OTBS
CO2Me
OTBS
+
rac-12
ii
3:1
Scheme 6 An unsuccessful result
© Georg Thieme Verlag Stuttgart · New York — Synlett 2018, 29, A–E